ABC News @ABC
Vaccine experts say the scientific rationale behind the FDA's move to stretch out the current monkeypox vaccine supply is sound, but technical challenges with the rollout technique may still be ahead. https://t.co/C32bJ7E4O0 — PolitiTweet.org